Eli Lilly and Company v. Teva Canada Limited (Novopharm Limited), 2010 FCA 338 (Atomoxetine*)
Justice Layden-Stevenson - 2010-12-10
Read full decision. Automatically generated summary:
The appellant and the respondent are in substantial agreement as to the contents of the appeal book. They have been unable to agree with respect to a few specific items. Hence, the motion before me is for the purpose of resolving those areas upon which they do not agree.
Decision relates to:
- A-387-10 - ELI LILLY AND COMPANY v. TEVA CANADA LIMITED which is an appeal from 2010 FC 915 in T-811-08